Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Summit Therapeutics
SMMT
$10.7B
| $781K | ﹤0.01% |
311,070
+296,489
| +2,033% | +$541K |
|
|
ITIC
2852
Investors Title Co
ITIC
$548M
| $781K | ﹤0.01% |
5,346
-172
| -3% | -$24.4K |
|
|
EU
2853
enCore Energy
EU
$219M
| $780K | ﹤0.01% |
+323,733
| New | +$723K |
|
2854
Innodata
INOD
$1.96B
| $780K | ﹤0.01% |
+68,827
| New | +$640K |
|
2855
Takeda Pharmaceutical
TAK
$55.1B
| $779K | ﹤0.01% |
49,563
+18,000
| +57% | +$295K |
|
2856
Oil-Dri
ODC
$1.42B
| $778K | ﹤0.01% |
+26,370
| New | +$584K |
|
2857
AST SpaceMobile
ASTS
$17.5B
| $774K | ﹤0.01% |
164,604
+138,517
| +531% | +$718K |
|
2858
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
| $773K | ﹤0.01% |
13,179
+1,771
| +16% | +$106K |
|
2859
Arbutus Biopharma
ABUS
$871M
| $773K | ﹤0.01% |
336,073
+27,104
| +9% | +$70.5K |
|
2860
Amalgamated Financial
AMAL
$1.48B
| $772K | ﹤0.01% |
47,953
+235
| +0.5% | +$3.77K |
|
2861
EVgo
EVGO
$236M
| $770K | ﹤0.01% |
192,620
+9,849
| +5% | +$50.3K |
|
2862
Destination XL Group
DXLG
$29.3M
| $766K | ﹤0.01% |
156,307
+1,734
| +1% | +$8.14K |
|
2863
inTEST
INTT
$155M
| $765K | ﹤0.01% |
+29,128
| New | +$642K |
|
2864
Viemed Healthcare
VMD
$451M
| $763K | ﹤0.01% |
+78,034
| New | +$792K |
|
2865
Five Star Bancorp
FSBC
$1.01B
| $763K | ﹤0.01% |
34,106
+530
| +2% | +$10.8K |
|
|
CRGE
2866
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $762K | ﹤0.01% |
777,579
-28,481
| -4% | -$28.9K |
|
|
PSTX
2867
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $756K | ﹤0.01% |
429,576
+168,830
| +65% | +$431K |
|
2868
National Grid
NGG
$80.8B
| $756K | ﹤0.01% |
11,915
+5,463
| +85% | +$358K |
|
|
SCPH
2869
DELISTED
scPharmaceuticals
SCPH
| $752K | ﹤0.01% |
+73,825
| New | +$770K |
|
2870
ACNB Corp
ACNB
$649M
| $750K | ﹤0.01% |
22,607
+424
| +2% | +$13.2K |
|
|
LLAP
2871
DELISTED
Terran Orbital Corporation
LLAP
| $749K | ﹤0.01% |
499,174
+104,096
| +26% | +$165K |
|
2872
Sutro Biopharma
STRO
$411M
| $748K | ﹤0.01% |
16,088
+1,494
| +10% | +$74.4K |
|
2873
5E Advanced Materials
FEAM
$46.1M
| $748K | ﹤0.01% |
9,912
-544
| -5% | -$51.7K |
|
2874
ESS Tech
GWH
$22.3M
| $747K | ﹤0.01% |
33,885
+1,873
| +6% | +$33.8K |
|
2875
South Plains Financial
SPFI
$842M
| $747K | ﹤0.01% |
33,168
+4,843
| +17% | +$105K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.